Annual EBITDA
$761.20M$11.20M+1.49%
Summary
- Current Value
- As of today, WST annual EBITDA is $761.20M, up +1.49% on
- Historical Performance
- WST annual EBITDA is down -13.90% over the past 3 years, up +44.14% over the past 5 years
- All-Time High Comparison
- WST annual EBITDA is currently -13.90% below its historical high of $884.10M set on
- 3-Year Low Comparison
- WST annual EBITDA is +1.49% above its 3-year low of $750.00M reached on
- Sector Comparison
- WST annual EBITDA is higher than 92.19% of companies in Healthcare sector
EBITDA Chart
SUGGESTED SERIES
Performance
| Metric | Date | Value | 1Y | 3Y | 5Y | 15Y |
|---|---|---|---|---|---|---|
| Annual EBITDA | $761.20M | +1.5% | -13.9% | +44.1% | +324.8% | |
| Quarterly EBITDA | $227.90M | +35.3% | +14.5% | +8.8% | +355.8% | |
| TTM EBITDA | $867.50M | +14.5% | +0.5% | +36.9% | +377.4% | |
| Price | $325.92 | +53.0% | -9.5% | -2.8% | +1281.3% | |
| PE Ratio | 43.57 | +30.2% | -11.8% | -27.5% | +72.6% | |
| Annual Revenue | $3.07B | +6.3% | +6.6% | +43.2% | +178.3% | |
| Annual EPS | $6.79 | +1.6% | -12.1% | +48.7% | +663.0% | |
| $589.80M | -0.8% | -22.8% | +40.8% | +456.4% | ||
| Annual Net Income | $493.70M | +0.2% | -15.7% | +42.6% | +656.0% |
EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 3Y | $884.10M | N/A | -13.9% |
| 5Y | $884.10M | -13.9% | |
| All | $884.10M | -13.9% |
EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 3Y | $750.00M | +1.5% | |
| 5Y | $528.10M | N/A | +44.1% |
| All | $23.45M | +3145.9% |
EBITDA History
FAQ
What is the current annual EBITDA of WST?
As of today, WST annual EBITDA is $761.20M
What is 1-year change in WST annual EBITDA?
WST annual EBITDA is up +1.49% year-over-year
What is 3-year change in WST annual EBITDA?
WST annual EBITDA is down -13.90% over the past 3 years
How far is WST annual EBITDA from its all-time high?
WST annual EBITDA is currently -13.90% below its historical high of $884.10M set on December 31, 2022
How does WST annual EBITDA rank versus sector peers?
WST annual EBITDA is higher than 92.19% of companies in Healthcare sector
When is WST next annual earnings release?
As of today, the next annual earnings release for WST has not been scheduled
Quarterly EBITDA
$227.90M$4.60M+2.06%
Summary
- Current Value
- As of today, WST quarterly EBITDA is $227.90M, up +2.06% on
- Historical Performance
- WST quarterly EBITDA is up +35.33% year-over-year, up +14.47% over the past 3 years
- All-Time High Comparison
- WST quarterly EBITDA is currently -10.28% below its historical high of $254.00M set on
- 3-Year Low Comparison
- WST quarterly EBITDA is +40.16% above its 3-year low of $162.60M reached on
- Sector Comparison
- WST quarterly EBITDA is higher than 92.37% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| Quarterly EBITDA | $227.90M | +2.1% | +35.3% | +14.5% | +8.8% | |
| Annual EBITDA | $761.20M | – | +1.5% | -13.9% | +44.1% | |
| TTM EBITDA | $867.50M | +7.4% | +14.5% | +0.5% | +36.9% | |
| Price | $325.92 | +32.4% | +53.0% | -9.5% | -2.8% | |
| PE Ratio | 43.57 | +20.3% | +30.2% | -11.8% | -27.5% | |
| Quarterly Revenue | $844.60M | +4.8% | +21.0% | +18.0% | +25.9% | |
| Quarterly EPS | $1.92 | +5.5% | +55.9% | +3.7% | -3.9% | |
| $177.60M | +0.7% | +38.3% | +6.0% | -1.5% | ||
| Quarterly Net Income | $138.80M | +5.1% | +54.6% | -0.9% | -8.2% |
Quarterly EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | $227.90M | at high | |
| 3Y | $227.90M | at high | |
| 5Y | $254.00M | -10.3% | |
| All | $254.00M | -10.3% |
Quarterly EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | $168.40M | N/A | +35.3% |
| 3Y | $162.60M | +40.2% | |
| 5Y | $162.60M | +40.2% | |
| All | -$192.90M | +218.1% |
Quarterly EBITDA History
FAQ
What is the current quarterly EBITDA of WST?
As of today, WST quarterly EBITDA is $227.90M
What is WST quarterly EBITDA most recent change?
WST quarterly EBITDA was up +2.06% on March 31, 2026
What is 1-year change in WST quarterly EBITDA?
WST quarterly EBITDA is up +35.33% year-over-year
How far is WST quarterly EBITDA from its all-time high?
WST quarterly EBITDA is currently -10.28% below its historical high of $254.00M set on June 30, 2022
How does WST quarterly EBITDA rank versus sector peers?
WST quarterly EBITDA is higher than 92.37% of companies in Healthcare sector
When is WST next earnings release?
The next earnings release for WST is on
TTM EBITDA
$867.50M$59.50M+7.36%
Summary
- Current Value
- As of today, WST TTM EBITDA is $867.50M, up +7.36% on
- Historical Performance
- WST TTM EBITDA is up +14.54% year-over-year, up +0.47% over the past 3 years
- All-Time High Comparison
- WST TTM EBITDA is currently -3.94% below its historical high of $903.10M set on
- 3-Year Low Comparison
- WST TTM EBITDA is +16.16% above its 3-year low of $746.80M reached on
- Sector Comparison
- WST TTM EBITDA is higher than 92.19% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| TTM EBITDA | $867.50M | +7.4% | +14.5% | +0.5% | +36.9% | |
| Annual EBITDA | $761.20M | – | +1.5% | -13.9% | +44.1% | |
| Quarterly EBITDA | $227.90M | +2.1% | +35.3% | +14.5% | +8.8% | |
| Price | $325.92 | +32.4% | +53.0% | -9.5% | -2.8% | |
| PE Ratio | 43.57 | +20.3% | +30.2% | -11.8% | -27.5% | |
| TTM Revenue | $3.22B | +4.8% | +11.2% | +11.8% | +38.5% | |
| TTM EPS | $7.48 | +10.1% | +17.5% | +2.6% | +34.0% | |
| $685.80M | +7.7% | +14.8% | -7.4% | +32.5% | ||
| TTM Net Income | $542.70M | +9.9% | +16.2% | -1.7% | +28.3% |
TTM EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | $867.50M | at high | |
| 3Y | $867.50M | at high | |
| 5Y | $903.10M | -3.9% | |
| All | $903.10M | -3.9% |
TTM EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | $757.40M | N/A | +14.5% |
| 3Y | $746.80M | +16.2% | |
| 5Y | $633.90M | N/A | +36.9% |
| All | -$171.90M | +604.6% |
TTM EBITDA History
FAQ
What is the current TTM EBITDA of WST?
As of today, WST TTM EBITDA is $867.50M
What is WST TTM EBITDA most recent change?
WST TTM EBITDA was up +7.36% on March 31, 2026
What is 1-year change in WST TTM EBITDA?
WST TTM EBITDA is up +14.54% year-over-year
How far is WST TTM EBITDA from its all-time high?
WST TTM EBITDA is currently -3.94% below its historical high of $903.10M set on September 30, 2022
How does WST TTM EBITDA rank versus sector peers?
WST TTM EBITDA is higher than 92.19% of companies in Healthcare sector
When is WST next earnings release?
The next earnings release for WST is on
EBITDA Formula
EBITDA = Net Income + + +
Data Sources & References
- WST Official Website www.westpharma.com
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/105770/000010577026000010/0000105770-26-000010-index.htm
- WST Profile on Yahoo Finance finance.yahoo.com/quote/WST
- WST Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/wst